Kidney cancer. Principles and practice. Second edition. Primo N. Lara, Jr. Eric Jonasch (Editors). Springer International Publishing (2015)

  1. Abel EJ, Culp SH, Tannir NM, Matin SF, Tamboli P, Jonasch E, Wood CG (2011) Primary tumor response to targeted agents in patients with metastatic renal cell carcinoma. Eur Urol 59(1):10–15
  2. Alt AL, Boorjian SA, Lohse CM, Costello BA, Leibovich BC, Blute ML (2011) Survival after complete surgical resection of multiple metastases from renal cell carcinoma. Cancer 117(13):2873–2882
  3. Althausen P, Althausen A, Jennings LC, Mankin HJ (1997) Prognostic factors and surgical treatment of osseous metastases secondary to renal cell carcinoma. Cancer 80(6):1103–1109
  4. Alves A, Adam R, Majno P, Delvart V, Azoulay D, Castaing D, Bismuth H (2003) Hepatic resection for metastatic renal tumors: is it worthwhile? Ann Surg Oncol 10(6):705–710
  5. Antonelli A, Zani D, Cozzoli A, Cunico SC (2005) Surgical treatment of metastases from renal cell carcinoma. Arch Ital Urol Androl 77(2):125–128
  6. Assouad J, Petkova B, Berna P, Dujon A, Foucault C, Riquet M (2007) Renal cell carcinoma lung metastases surgery: pathologic findings and prognostic factors. Ann Thorac Surg 84(4):1114–1120
  7. Assouad J, Riquet M, Berna P, Danel C (2007) Intrapulmonary lymph node metastasis and renal cell carcinoma. Eur J Cardiothorac Surg 31(1):132–134
  8. Assouad J, Riquet M, Foucault C, Hidden G, Delmas V (2006) Renal lymphatic drainage and thoracic duct connections: implications for cancer spread. Lymphology 39:26–32
  9. Badalament RA, Gluck RW, Wong GY, Gnecco C, Kreutzer E, Herr HW, Fair WR, Galicich JH (1990) Surgical treatment of brain metastases from renal cell carcinoma. Urology 36(2):112–117
  10. Baloch KG, Grimer RJ, Carter SR, Tillman RM (2000) Radical surgery for the solitary bony metastasis from renal-cell carcinoma. J Bone Joint Surg Br 82(1):62–67
  11. Barney JD, Churchill J (1939) Adenocarcinoma of the kidney with metastasis to the lung. J Urol 42(269):271
  12. Benoit L, Favoulet P, Arnould L, Margarot A, Franceschini C, Collin F, Fraisse J, Cuisenier J, Cougard P (2004) Metastatic renal cell carcinoma to the thyroid gland: report of seven cases and review of the literature. Ann Chir 129(4):218–223
  13. Bex A, Jonasch E, Kirkali Z, Mejean A, Mulders P, Oudard S, Patard JJ, Powles T, Van Poppel H, Wood CG (2010) Integrating surgery with targeted therapies for renal cell carcinoma: current evidence and ongoing trials. Eur Urol 58(6):819–828
  14. Bex A, van der Veldt AA, Blank C, van den Eertwegh AJ, Boven E, Horenblas S, Haanen J (2009) Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery. World J Urol 27(4):533–539
  15. Bianchi M, Sun M, Jeldres C, Shariat SF, Trinh QD, Briganti A, Tian Z, Schmitges J, Graefen M, Perrotte P, Menon M, Montorsi F, Karakiewicz PI (2012) Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol 23(4):973–980
  16. Cannady SB, Cavanaugh KA, Lee SY, Bukowski RM, Olencki TE, Stevens GH, Barnett GH, Suh JH (2004) Results of whole brain radiotherapy and recursive partitioning analysis in patients with brain metastases from renal cell carcinoma: a retrospective study. Int J Radiat Oncol Biol Phys 58(1):253–258
  17. Cerfolio RJ, Allen MS, Deschamps C, Daly RC, Wallrichs SL, Trastek VF, Pairolero PC (1994) Pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 57(2):339–344
  18. Cowey CL, Amin C, Pruthi RS, Wallen EM, Nielsen ME, Grigson G, Watkins C, Nance KV, Crane J, Jalkut M, Moore DT, Kim WY, Godley PA, Whang YE, Fielding JR, Rathmell WK (2010) Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma. J Clin Oncol 28(9):1502–1507
  19. Dabestani S, Marconi L, Hofmann F, Stewart F, Lam TBL, Canfield SE, Staehler M, Powles T, Ljungberg B, Bex A (2014) Local treatments for metastases of renalcell carcinoma: a systematic review. Lancet Oncol 15(12):e549–e561
  20. Daliani DD, Tannir NM, Papandreou CN, Wang X, Swisher S, Wood CG, Swanson DA, Logothetis CJ, Jonasch E (2009) Prospective assessment of systemic therapy followed by surgical removal of metastases in selected patients with renal cell carcinoma. BJU Int 104(4):456–460
  21. De Meerleer G, Khoo V, Escudier B, Joniau S, Bossi A, Ost P, Briganti A, Fonteyne V, Van Vulpen M, Lumen N, Spahn M, Mareel M (2014) Radiotherapy for renalcell carcinoma. Lancet Oncol 15(4):e170–e177
  22. Decker DA, Decker VL, Herskovic A, Cummings GD (1984) Brain metastases in patients with renal cell carcinoma: prognosis and treatment. J Clin Oncol 2(3):169–173
  23. deKernion JB, Ramming KP, Smith RB (1978) The natural history of metastatic renal cell carcinoma: a computer analysis. J Urol 120:148–152
  24. Dernevik L, Berggren H, Larsson S, Roberts D (1985) Surgical removal of pulmonary metastases from renal cell carcinoma. Scand J Urol Nephrol 19(2):133–137
  25. Dieckmann KP, Wullbrand A, Krolzig G (1996) Contralateral adrenal metastasis in renal cell cancer. Scand J Urol Nephrol 30(2):139–143
  26. Durr HR, Maier M, Pfahler M, Baur A, Refior HJ (1999) Surgical treatment of osseous metastases in patients with renal cell carcinoma. Clin Orthop Relat Res 367:283–290
  27. Dutcher JP, Mourad WF, Ennis RD (2012) Integrating innovative therapeutic strategies into the management of renal cell carcinoma. Oncology (Williston Park) 26(6):526–530, 532, 534
  28. Eggener SE, Yossepowitch O, Kundu S, Motzer RJ, Russo P (2008) Risk score and metastasectomy independently impact prognosis of patients with recurrent renal cell carcinoma. J Urol 180(3):873–878
  29. Eggener SE, Yossepowitch O, Pettus JA, Snyder ME, Motzer RJ, Russo P (2006) Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. J Clin Oncol 24(19):3101–3106
  30. Escudier B, Goupil MG, Massard C, Fizazi K (2009) Sequential therapy in renal cell carcinoma. Cancer 115(10 Suppl):2321–2326
  31. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18(3): 581–592
  32. Flanigan RC, Yonover PM (2001) The role of radical nephrectomy in metastatic renal cell carcinoma. Semin Urol Oncol 19(2):98–102
  33. Fourquier P, Regnard JF, Rea S, Levi JF, Levasseur P (1997) Lung metastases of renal cell carcinoma: results of surgical resection. Eur J Cardiothorac Surg 11(1):17–21
  34. Freedland SJ, deKernion JB (2003) Role of lymphadenectomy for patients undergoing radical nephrectomy for renal cell carcinoma. Rev Urol 5(3):191–195
  35. Friedel G, Hurtgen M, Penzenstadler M, Kyriss T, Toomes H (1999) Resection of pulmonary metastases from renal cell carcinoma. Anticancer Res 19(2C):1593–1596
  36. Fujisaki S, Takayama T, Shimada K, Yamamoto J, Kosuge T, Yamasaki S, Tobisu K, Kurosu Y, Makuuchi M (1997) Hepatectomy for metastatic renal cell carcinoma. Hepatogastroenterology 44(15):817–819
  37. Fukuda M, Satomi Y, Senga Y, Suzaki H, Nakahashi M, Ide K, Kondo I (1987) Results of pulmonary resection for metastatic renal cell carcinoma. Hinyokika Kiyo 33(7):993–997
  38. Gaspar LE, Scott C, Murray K, Curran W (2000) Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47(4):1001–1006
  39. Goering JD, Mahvi DM, Niederhuber JE, Chicks D, Rikkers LF (2002) Cryoablation and liver resection for noncolorectal liver metastases. Am J Surg 183(4):384–389
  40. Golimbu M, al Askari S, Tessler A, Morales P (1986) Aggressive treatment of metastatic renal cancer. J Urol 136(4):805–807
  41. Han KR, Pantuck AJ, Bui MH, Shvarts O, Freitas DG, Zisman A, Leibovich BC, Dorey FJ, Gitlitz BJ, Figlin RA, Belldegrun AS (2003) Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma. Urology 61(2):314–319
  42. Heffess CS, Wenig BM, Thompson LD (2002) Metastatic renal cell carcinoma to the thyroid gland: a clinicopathologic study of 36 cases. Cancer 95(9): 1869–1878
  43. Hellenthal NJ, Underwood W, Penetrante R, Litwin A, Zhang S, Wilding GE, Teh BT, Kim HL (2010) Prospective clinical trial of preoperative sunitinib in patients with renal cell carcinoma. J Urol 184(3): 859–864
  44. Hellsten S, Berge T, Linell F (1983) Clinically unrecognised renal carcinoma: aspects of tumor morphology, lymphatic and haematogenous metastatic spread. Br J Urol 55(2):166–170
  45. Heng DY, Rini BI, Garcia J, Wood L, Bukowski RM (2007) Prolonged complete responses and nearcomplete responses to sunitinib in metastatic renal cell carcinoma. Clin Genitourin Cancer 5(7):446–451
  46. Heng DY, Xie W, Regan MM, Warren MA, Golshayan AR, Sahi C, Eigl BJ, Ruether JD, Cheng T, North S, Venner P, Knox JJ, Chi KN, Kollmannsberger C, McDermott DF, Oh WK, Atkins MB, Bukowski RM, Rini BI, Choueiri TK (2009) Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study. J Clin Oncol 27(34):5794–5799
  47. Hoffmann RT, Jakobs TF, Trumm C, Weber C, Helmberger TK, Reiser MF (2008) Radiofrequency ablation in combination with osteoplasty in the treatment of painful metastatic bone disease. J Vasc Interv Radiol 19(3):419–425
  48. Hofmann HS, Neef H, Krohe K, Andreev P, Silber RE (2005) Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol 48(1):77–81
  49. Hulten L, Rosencrantz M, Seeman T, Wahlqvist L, Ahren C (1969) Occurrence and localization of lymph node metastases in renal carcinoma. Scand J Urol Nephrol 3:129–133
  50. Ibrahim A, Crockard A, Antonietti P, Boriani S, Bunger C, Gasbarrini A, Grejs A, Harms J, Kawahara N, Mazel C, Melcher R, Tomita K (2008) Does spinal surgery improve the quality of life for those with extradural (spinal) osseous metastases? An international multicenter prospective observational study of 223 patients. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2007. J Neurosurg Spine 8(3):271–278
  51. Iesalnieks I, Winter H, Bareck E, Sotiropoulos GC, Goretzki PE, Klinkhammer-Schalke M, Brockner S, Trupka A, Anthuber M, Rupprecht H, Raab M, Meyer W, Reichmann F, Kastel M, Mayr M, Braun W, Schlitt HJ, Agha A (2008) Thyroid metastases of renal cell carcinoma: clinical course in 45 patients undergoing surgery. Assessment of factors affecting patients’ survival. Thyroid 18(6):615–624
  52. Itano NB, Blute ML, Spotts B, Zincke H (2000) Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy. J Urol 164(2):322–325
  53. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4):225–249
  54. Johannsen M, Florcken A, Bex A, Roigas J, Cosentino M, Ficarra V, Kloeters C, Rief M, Rogalla P, Miller K, Grunwald V (2008) Can tyrosine kinase inhibitors be discontinued in patients with metastatic renal cell carcinoma and a complete response to treatment? A multicentre, retrospective analysis. Eur Urol 55(6):1430–1438
  55. Johannsen M, Staehler M, Ohlmann CH, Florcken A, Schmittel A, Otto T, Bex A, Hein P, Miller K, Weikert S, Grunwald V (2011) Outcome of treatment discontinuation in patients with metastatic renal cell carcinoma and no evidence of disease following targeted therapy with or without metastasectomy. Ann Oncol 22(3):657–663
  56. Johnsen JA, Hellsten S (1997) Lymphatogenous spread of renal cell carcinoma: an autopsy study. J Urol 157:450–453
  57. Jung ST, Ghert MA, Harrelson JM, Scully SP (2003) Treatment of osseous metastases in patients with renal cell carcinoma. Clin Orthop Relat Res 409:223–231
  58. Kanzaki R, Higashiyama M, Fujiwara A, Tokunaga T, Maeda J, Okami J, Nishimura K, Kodama K (2011) Long-term results of surgical resection for pulmonary metastasis from renal cell carcinoma: a 25-year single-institution experience. Eur J Cardiothorac Surg 39(2):167–172
  59. Kanzaki R, Higashiyama M, Okami J, Kodama K (2009) Surgical treatment for patients with solitary metastasis in the mediastinal lymph node from renal cell carcinoma. Interact Cardiovasc Thorac Surg 8(4):485–487
  60. Karam JA, Devine CE, Urbauer DL, Lozano M, Maity T, Ahrar K, Tamboli P, Tannir NM, Wood CG (2014) Phase 2 trial of neoadjuvant axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma. Eur Urol 66(5):874–880
  61. Karam JA, Rini BI, Varella L, Garcia JA, Dreicer R, Choueiri TK, Jonasch E, Matin SF, Campbell SC, Wood CG, Tannir NM (2011) Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma. J Urol 185(2):439–444
  62. Kato S, Murakami H, Takeuchi A, Demura S, Yoshioka K, Kawahara N, Tomita K, Tsuchiya H (2013) Fifteenyear survivor of renal cell carcinoma after metastasectomies for multiple bone metastases. Orthopedics 36(11): e1454–e1457
  63. Katzenstein AL, Purvis R Jr, Gmelich J, Askin F (1978) Pulmonary resection for metastatic renal adenocarcinoma: pathologic findings and therapeutic value. Cancer 41(2):712–723
  64. Kavolius JP, Mastorakos DP, Pavlovich C, Russo P, Burt ME, Brady MS (1998) Resection of metastatic renal cell carcinoma. J Clin Oncol 16(6):2261–2266
  65. Kessler OJ, Mukamel E, Weinstein R, Gayer E, Konichezky M, Servadio C (1998) Metachronous renal cell carcinoma metastasis to the contralateral adrenal gland. Urology 51(4):539–543
  66. Kierney PC, van Heerden JA, Segura JW, Weaver AL (1994) Surgeon’s role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: an institutional review. Ann Surg Oncol 1(4):345–352
  67. Kollender Y, Bickels J, Price WM, Kellar KL, Chen J, Merimsky O, Meller I, Malawer MM (2000) Metastatic renal cell carcinoma of bone: indications and technique of surgical intervention. J Urol 164(5):1505–1508
  68. Krishnamurthi V, Novick AC, Bukowski RM (1998) Efficacy of multimodality therapy in advanced renal cell carcinoma. Urology 51(6):933–937
  69. Kuczyk M, Munch T, Machtens S, Bokemeyer C, Wefer A, Hartmann J, Kollmannsberger C, Kondo M, Jonas U (2002) The need for routine adrenalectomy during surgical treatment for renal cell cancer: the Hannover experience. BJU Int 89(6):517–522
  70. Kudelin N, Bolukbas S, Eberlein M, Schirren J (2013) Metastasectomy with standardized lymph node dissection for metastatic renal cell carcinoma: an 11-year single-center experience. Ann Thorac Surg 96(1): 265–270
  71. Lang H, Nussbaum KT, Weimann A, Raab R (1999) Liver resection for non-colorectal, non-neuroendocrine hepatic metastases. Chirurg 70(4):439–446
  72. Lau WK, Zincke H, Lohse CM, Cheville JC, Weaver AL, Blute ML (2003) Contralateral adrenal metastasis of renal cell carcinoma: treatment, outcome and a review. BJU Int 91(9):775–779
  73. Leibovich BC, Cheville JC, Lohse CM, Zincke H, Frank I, Kwon ED, Merchan JR, Blute ML (2005) A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. J Urol 174(5):1759–1763
  74. Les KA, Nicholas RW, Rougraff B, Wurtz D, Vogelzang NJ, Simon MA, Peabody TD (2001) Local progression after operative treatment of metastatic kidney cancer. Clin Orthop Relat Res 390:206–211
  75. Levy DA, Slaton JW, Swanson DA, Dinney CP (1998) Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol 159(4):1163–1167
  76. Linton RR, Barney JD (1946) Metastatic hypernephroma of the thyroid gland. Surg Gynecol Obstet 83:493–498
  77. Ljungberg B, Alamdari FI, Rasmuson T, Roos G (1999) Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy. BJU Int 84(4):405–411
  78. Lokich J (1997) Spontaneous regression of metastatic renal cancer. Case report and literature review. Am J Clin Oncol 20(4):416–418
  79. Mahon TG, Libshitz HI (1992) Mediastinal metastases of infradiaphragmatic malignancies. Eur J Radiol 15(2):130–134
  80. Margulis V, Matin SF, Tannir N, Tamboli P, Swanson DA, Jonasch E, Wood CG (2008) Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma. J Urol 180:94–98
  81. Margulis V, McDonald M, Tamboli P, Swanson DA, Wood CG (2009) Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma. J Urol 181(5):2044–2051
  82. Marko NF, Angelov L, Toms SA, Suh JH, Chao ST, Vogelbaum MA, Barnett GH, Weil RJ (2010) Stereotactic radiosurgery as single-modality treatment of incidentally identified renal cell carcinoma brain metastases. World Neurosurg 73(3):186–193
  83. Marulli G, Sartori F, Bassi PF, dal Moro F, Gino Favaretto A, Rea F (2006) Long-term results of surgical management of pulmonary metastases from renal cell carcinoma. Thorac Cardiovasc Surg 54(8):544–547
  84. Meimarakis G, Angele M, Staehler M, Clevert DA, Crispin A, Ruttinger D, Lohe F, Preissler G, Hatz RA, Winter H (2011) Evaluation of a new prognostic score (Munich score) to predict long-term survival after resection of pulmonary renal cell carcinoma metastases. Am J Surg 202(2):158–167
  85. Middleton RG (1967) Surgery for metastatic renal cell carcinoma. J Urol 97(6):973–977
  86. Mineo TC, Ambrogi V, Tonini G, Nofroni I (2001) Pulmonary metastasectomy: might the type of resection affect survival? J Surg Oncol 76(1):47–52
  87. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Oudard S, Negrier S, Szczylik C, Pili R, Bjarnason GA, Garcia-del-Muro X, Sosman JA, Solska E, Wilding G, Thompson JA, Kim ST, Chen I, Huang X, Figlin RA (2009) Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol 27(22):3584–3590
  88. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik C, Kim ST, Chen I, Bycott PW, Baum CM, Figlin RA (2007) Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356(2):115–124
  89. Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J (1999) Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 17(8):2530–2540
  90. Muacevic A, Kreth FW, Horstmann GA, SchmidElsaesser R, Wowra B, Steiger HJ, Reulen HJ (1999) Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter. J Neurosurg 91(1):35–43
  91. Muacevic A, Kreth FW, Mack A, Tonn JC, Wowra B (2004) Stereotactic radiosurgery without radiation therapy providing high local tumor control of multiple brain metastases from renal cell carcinoma. Minim Invasive Neurosurg 47(4):203–208
  92. Murthy SC, Kim K, Rice TW, Rajeswaran J, Bukowski R, DeCamp MM, Blackstone EH (2005) Can we predict long-term survival after pulmonary metastasectomy for renal cell carcinoma? Ann Thorac Surg 79(3):996–1003
  93. Naito S, Kinoshita H, Kondo T, Shinohara N, Kasahara T, Saito K, Takayama T, Masumori N, Takahashi W, Takahashi M, Terachi T, Ozono S, Naito S, Tomita Y (2013) Prognostic factors of patients with metastatic renal cell carcinoma with removed metastases: a multicenter study of 556 patients. Urology 82(4):846–851
  94. Naito S, Yamamoto N, Takayama T, Muramoto M, Shinohara N, Nishiyama K, Takahashi A, Maruyama R, Saika T, Hoshi S, Nagao K, Yamamoto S, Sugimura I, Uemura H, Koga S, Takahashi M, Ito F, Ozono S, Terachi T, Naito S, Tomita Y (2010) Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients. Eur Urol 57(2):317–325
  95. Nguyen QN, Shiu AS, Rhines LD, Wang H, Allen PK, Wang XS, Chang EL (2010) Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 76(4):1185–1192
  96. Noordijk EM, Vecht CJ, Haaxma-Reiche H, Padberg GW, Voormolen JH, Hoekstra FH, Tans JT, Lambooij N, Metsaars JA, Wattendorff AR (1994) The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys 29(4):711–717
  97. O’Dea MJ, Zincke H, Utz DC, Bernatz PE (1978) The treatment of renal cell carcinoma with solitary metastasis. J Urol 120(5):540–542
  98. Oddsson SJ, Hardarson S, Petursdottir V, Jonsson E, Sigurdsson MI, Einarsson GV, Pfannschmidt J, Gudbjartsson T (2012) Synchronous pulmonary metastases from renal cell carcinoma – a whole nation study on prevalence and potential resectability. Scand J Surg 101(3):160–165
  99. Onishi T, Ohishi Y, Goto H, Suzuki H, Asano K (2000) Metachronous solitary metastasis of renal cell carcinoma to the contralateral adrenal gland after nephrectomy. Int J Clin Oncol 5(1):36–40
  100. Pantuck AJ, Zisman A, Dorey F, Chao DH, Han KR, Said J, Gitlitz B, Belldegrun AS, Figlin RA (2003) Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy. Cancer 97(12):2995–3002
  101. Pantuck AJ, Zisman A, Dorey F, Chao DH, Han KR, Said J, Gitlitz B, Figlin RA, Belldegrun AS (2003) Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. J Urol 169(6):2076–2083
  102. Patard JJ, Thuret R, Raffi A, Laguerre B, Bensalah K, Culine S (2008) Treatment with sunitinib enabled complete resection of massive lymphadenopathy not previously amenable to excision in a patient with renal cell carcinoma. Eur Urol 55(1):237–239
  103. Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, Mohiuddin M, Young B (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366(9486): 643–648
  104. Patil S, Figlin RA, Hutson TE, Michaelson MD, Negrier S, Kim ST, Huang X, Motzer RJ (2011) Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma. Ann Oncol 22(2):295–300
  105. Paul R, Mordhorst J, Leyh H, Hartung R (2001) Incidence and outcome of patients with adrenal metastases of renal cell cancer. Urology 57(5):878–882
  106. Pfannschmidt J, Hoffmann H, Muley T, Krysa S, Trainer C, Dienemann H (2002) Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 74(5):1653–1657
  107. Phillips CK, Taneja SS (2004) The role of lymphadenectomy in the surgical management of renal cell carcinoma. Urol Oncol 22(3):214–223
  108. Piltz S, Meimarakis G, Wichmann MW, Hatz R, Schildberg FW, Fuerst H (2002) Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg 73(4):1082–1087
  109. Powles T, Kayani I, Blank C, Chowdhury S, Horenblas S, Peters J, Shamash J, Sarwar N, Boletti K, Sadev A, O’Brien T, Berney D, Beltran L, Haanen J, Bex A (2011) The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer. Ann Oncol 22(5):1041–1047
  110. Rafla S (1970) Renal cell carcinoma. Natural history and results of treatment. Cancer 25(1):26–40
  111. Renaud S, Falcoz PE, Alifano M, Olland A, Magdeleinat P, Pages O, Regnard JF, Massard G (2014) Systematic lymph node dissection in lung metastasectomy of renal cell carcinoma: an 18 years of experience. J Surg Oncol 109(8):823–829
  112. Rini BI, Shaw V, Rosenberg JE, Kim ST, Chen I (2006) Patients with metastatic renal cell carcinoma with long term disease-free survival after treatment with sunitinib and resection of residual metastases. Clin Genitourin Cancer 5(3):232–234
  113. Riquet M, Le Pimpec Barthes F, Souilamas R, Hidden G (2002) Thoracic duct tributaries from intrathoracic organs. Ann Thorac Surg 73(3):892–898
  114. Ritchie AW, deKernion JB (1987) The natural history and clinical features of renal carcinoma. Semin Nephrol 7(2):131–139
  115. Russo P, Synder M, Vickers A, Kondagunta V, Motzer R (2007) Cytoreductive nephrectomy and nephrectomy/complete metastasectomy for metastatic renal cancer. Sci World J 7:768–778
  116. Saitoh H, Nakayama M, Nakamura K, Satoh T (1982) Distant metastasis of renal adenocarcinoma in nephrectomized cases. J Urol 127:1092–1095
  117. Sandock DS, Seftel AD, Resnick MI (1995) A new protocol for the followup of renal cell carcinoma based on pathological stage. J Urol 154(1):28–31
  118. Schrodter S, Hakenberg OW, Manseck A, Leike S, Wirth MP (2002) Outcome of surgical treatment of isolated local recurrence after radical nephrectomy for renal cell carcinoma. J Urol 167(4):1630–1633
  119. Sella A, Swanson DA, Ro JY, Putnam JB Jr, Amato RJ, Markowitz AB, Logothetis CJ (1993) Surgery following response to interferon-alpha-based therapy for residual renal cell carcinoma. J Urol 149(1):19–21
  120. Sheehan JP, Sun MH, Kondziolka D, Flickinger J, Lunsford LD (2003) Radiosurgery in patients with renal cell carcinoma metastasis to the brain: longterm outcomes and prognostic factors influencing survival and local tumor control. J Neurosurg 98(2):342–349
  121. Sherry RM, Pass HI, Rosenberg SA, Yang JC (1992) Surgical resection of metastatic renal cell carcinoma and melanoma after response to interleukin-2-based immunotherapy. Cancer 69(7):1850–1855
  122. Shu Yan Huo A, Lawson Morris D, King J, Glenn D (2009) Use of percutaneous radiofrequency ablation in pulmonary metastases from renal cell carcinoma. Ann Surg Oncol 16(11):3169–3175
  123. Shuch B, La Rochelle JC, Klatte T, Riggs SB, Liu W, Kabbinavar FF, Pantuck AJ, Belldegrun AS (2008) Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival. Cancer 113(7):1641–1648
  124. Shuch B, Riggs SB, LaRochelle JC, Kabbinavar FF, Avakian R, Pantuck AJ, Patard JJ, Belldegrun AS (2008) Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm. BJU Int 102(6):692–696, April 10 Epub ahead of print
  125. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64(1):9–29
  126. Siemer S, Lehmann J, Kamradt J, Loch T, Remberger K, Humke U, Ziegler M, Stockle M (2004) Adrenal metastases in 1635 patients with renal cell carcinoma: outcome and indication for adrenalectomy. J Urol 171(6 Pt 1):2155–2159
  127. Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF (1971) Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer 28(5):1165–1177
  128. Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, Bhatt A, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Schwer A, Gaspar LE, Fiveash JB, Chiang V, Knisely J, Sperduto CM, Mehta M (2010) Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 77(3):655–661
  129. Staehler M, Haseke N, Zilinberg E, Stadler T, Karl A, Siebels M, Durr HR, Siegert S, Jauch KW, Bruns CJ, Stief CG (2010) Complete remission achieved with angiogenic therapy in metastatic renal cell carcinoma including surgical intervention. Urol Oncol 28(2):139–144
  130. Staehler MD, Kruse J, Haseke N, Stadler T, Roosen A, Karl A, Stief CG, Jauch KW, Bruns CJ (2010) Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. World J Urol 28(4):543–547
  131. Stief CG, Jahne J, Hagemann JH, Kuczyk M, Jonas U (1997) Surgery for metachronous solitary liver metastases of renal cell carcinoma. J Urol 158(2): 375–377
  132. Svedman C, Sandstrom P, Pisa P, Blomgren H, Lax I, Kalkner KM, Nilsson S, Wersall P (2006) A prospective phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma. Acta Oncol 45(7):870–875
  133. Swanson DA (2004) Surgery for metastases of renal cell carcinoma. Scand J Surg 93(2):150–155
  134. Swanson DA, Orovan WL, Johnson DE, Giacco G (1981) Osseous metastases secondary to renal cell carcinoma. Urology 18(6):556–561
  135. Szendroi A, Szendroi M, Szucs M, Szekely E, Romics I (2010) 11-year survival of a renal cell cancer patient following multiple metastasectomy. Can J Urol 17(6):5475–5477
  136. Tanguay S, Swanson DA, Putnam JB Jr (1996) Renal cell carcinoma metastatic to the lung: potential benefit in the combination of biological therapy and surgery. J Urol 156(5):1586–1589
  137. Tanis PJ, van der Gaag NA, Busch OR, van Gulik TM, Gouma DJ (2009) Systematic review of pancreatic surgery for metastatic renal cell carcinoma. Br J Surg 96(6):579–592
  138. Thelen A, Jonas S, Benckert C, Lopez-Hanninen E, Rudolph B, Neumann U, Neuhaus P (2007) Liver resection for metastases from renal cell carcinoma. World J Surg 31(4):802–807
  139. Thibault F, Rixe O, Meric JB, Renard-Penna R, Boostan H, Mozer P, Comperat E, Richard F, Bitker MO (2008) Neoadjuvant therapy for renal cancer. Prog Urol 18(4):256–258
  140. Tolia BM, Whitmore WF Jr (1975) Solitary metastasis from renal cell carcinoma. J Urol 114(6): 836–838
  141. Tongaonkar HB, Kulkarni JN, Kamat MR (1992) Solitary metastases from renal cell carcinoma: a review. J Surg Oncol 49(1):45–48
  142. Tosco L, Van Poppel H, Frea B, Gregoraci G, Joniau S (2013) Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma. Eur Urol 63(4):646–652
  143. Toyota N, Naito A, Kakizawa H, Hieda M, Hirai N, Tachikake T, Kimura T, Fukuda H, Ito K (2005) Radiofrequency ablation therapy combined with cementoplasty for painful bone metastases: initial experience. Cardiovasc Intervent Radiol 28(5): 578–583
  144. Tsui KH, Shvarts O, Barbaric Z, Figlin R, de Kernion JB, Belldegrun A (2000) Is adrenalectomy a necessary component of radical nephrectomy? UCLA experience with 511 radical nephrectomies. J Urol 163(2):437–441
  145. van der Poel HG, Roukema JA, Horenblas S, van Geel AN, Debruyne FM (1999) Metastasectomy in renal cell carcinoma: a multicenter retrospective analysis. Eur Urol 35(3):197–203
  146. Vecht CJ, Haaxma-Reiche H, Noordijk EM, Padberg GW, Voormolen JH, Hoekstra FH, Tans JT, Lambooij N, Metsaars JA, Wattendorff AR (1993) Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 33(6): 583–590
  147. Vogelzang NJ, Priest ER, Borden L (1992) Spontaneous regression of histologically proved pulmonary metastases from renal cell carcinoma: a case with 5-year followup. J Urol 148(4):1247–1248
  148. Welch BT, Atwell TD, Nichols DA, Wass CT, Callstrom MR, Leibovich BC, Carpenter PC, Mandrekar JN, Charboneau JW (2011) Percutaneous image-guided adrenal cryoablation: procedural considerations and technical success. Radiology 258(1): 301–307
  149. Winter H, Meimarakis G, Angele MK, Hummel M, Staehler M, Hoffmann RT, Hatz RA, Lohe F (2010) Tumor infiltrated hilar and mediastinal lymph nodes are an independent prognostic factor for decreased survival after pulmonary metastasectomy in patients with renal cell carcinoma. J Urol 184(5): 1888–1894
  150. Wright FW (1977) Enlarged hilar and mediastinal nodes (and especially lower right hilar node enlargement) as a sign of metastasis of a renal tumour. Clin Radiol 28(4):431–436
  151. Wronski M, Arbit E, Russo P, Galicich JH (1996) Surgical resection of brain metastases from renal cell carcinoma in 50 patients. Urology 47(2): 187–193
  152. Wronski M, Maor MH, Davis BJ, Sawaya R, Levin VA (1997) External radiation of brain metastases from renal carcinoma: a retrospective study of 119 patients from the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 37(4):753–759
  153. Yamaguchi K, Kawata N, Nagane Y, Igarashi H, Sugimoto S, Hirakata H, Takahashi S, Higaki T (2010) Metastasectomy for renal cell carcinoma as a strategy to obtain complete remission. Int J Clin Oncol 15(5):519–522

[contact-form-7 id=»5168″ title=»Контактная форма 1″]


Добавить комментарий

Войти с помощью: 

Ваш e-mail не будет опубликован. Обязательные поля помечены *